Statements (29)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
inhalable insulin |
| gptkbp:activeIngredient |
human insulin
|
| gptkbp:approvalYear |
2014
|
| gptkbp:ATCCode |
A10AB08
|
| gptkbp:contraindication |
gptkb:COPD
asthma chronic lung disease |
| gptkbp:deliveryDevice |
inhaler
|
| gptkbp:form |
dry powder
|
| gptkbp:halfLife |
~28-39 minutes
|
| https://www.w3.org/2000/01/rdf-schema#label |
Afrezza
|
| gptkbp:indication |
gptkb:type_2_diabetes
type 1 diabetes |
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:MannKind_Corporation
|
| gptkbp:marketedAs |
gptkb:MannKind_Corporation
gptkb:Sanofi |
| gptkbp:onset |
gptkb:fire
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:routeOfAdministration |
inhalation
|
| gptkbp:sideEffect |
gptkb:hypoglycemia
cough bronchospasm throat pain |
| gptkbp:usedFor |
gptkb:diabetes_mellitus
|
| gptkbp:website |
https://www.afrezza.com/
|
| gptkbp:bfsParent |
gptkb:insulin
|
| gptkbp:bfsLayer |
6
|